Nyrada Inc - Asset Resilience Ratio

Latest as of June 2025: 55.29%

Nyrada Inc (NYR) has an Asset Resilience Ratio of 55.29% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

AU$2.93 Million

≈ $2.07 Million USD Cash + Short-term Investments

Total Assets

AU$5.30 Million

≈ $3.75 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2022)

This chart shows how Nyrada Inc's Asset Resilience Ratio has changed over time. Check NYR PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Nyrada Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see NYR stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$2.93 Million	55.29%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$2.93 Million	55.29%

Asset Resilience Insights

Very High Liquidity: Nyrada Inc maintains exceptional liquid asset reserves at 55.29% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Nyrada Inc Industry Peers by Asset Resilience Ratio

Compare Nyrada Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	10.93%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	57.90%
TELIX Pharmaceuticals Ltd AU:TLX	Biotechnology	32.29%
Inner Mongolia Furui Med Sci SHE:300049	Biotechnology	2.34%
Bicara Therapeutics Inc. Common Stock NASDAQ:BCAX	Biotechnology	39.07%
Damora Therapeutics, Inc. NASDAQ:DMRA	Biotechnology	0.00%

Annual Asset Resilience Ratio for Nyrada Inc (2021–2022)

The table below shows the annual Asset Resilience Ratio data for Nyrada Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-06-30	90.03%	AU$10.82 Million ≈ $7.65 Million	AU$12.01 Million ≈ $8.50 Million	-0.70pp
2021-06-30	90.72%	AU$13.75 Million ≈ $9.73 Million	AU$15.16 Million ≈ $10.72 Million	--

pp = percentage points

About Nyrada Inc

AU:NYR Australia Biotechnology

Market Cap

$128.25 Million

AU$181.26 Million AUD

Market Cap Rank

#18259 Global

#563 in Australia

Share Price

AU$0.74

Change (1 day)

-0.67%

52-Week Range

AU$0.24 - AU$1.38

All Time High

AU$1.38